Related Experiment Video
Updated: Feb 10, 2026

External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Chloral Hydrate Administered by a Dedicated Sedation Service Can Be Used Safely and Effectively for Pediatric
Mohammed Karaoui1, Varshini Varadaraj2, Beatriz Munoz2
1King Khaled Eye Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Insights
Oral chloral hydrate sedation is safe and effective for pediatric eye procedures, achieving high success rates with minimal adverse events. This method supports efficient outpatient care for young patients undergoing ophthalmic evaluations.
Area of Science:
- Ophthalmology
- Pediatric Sedation
- Pharmacology
Background:
- Outpatient pediatric ophthalmic procedures require safe and effective sedation methods.
- Chloral hydrate is a commonly used sedative for children.
Purpose of the Study:
- To evaluate the safety and efficacy of oral chloral hydrate sedation (CHS) for pediatric outpatient ophthalmic procedures.
- To assess sedation levels, vital signs, and adverse events in children receiving CHS.
Main Methods:
- A prospective, interventional case series was conducted at King Khaled Eye Specialist Hospital.
- 324 children aged 1 month to 5 years received oral chloral hydrate for ocular imaging or evaluation.
- Data collected included chloral hydrate dosage, sedation success, vital signs, and adverse events.
Main Results:
- 96.3% of patients achieved adequate sedation with oral chloral hydrate (mean dose: 77.4 mg/kg).
- Significant but minor reductions in heart rate, respiratory rate, and oxygen saturation were observed.
- Higher American Society of Anesthesiologists (ASA) class and more planned procedures were associated with longer sedation duration.
Conclusions:
- Oral chloral hydrate, administered by a dedicated sedation service, is a safe and effective option for outpatient pediatric ophthalmic procedures.
- The study supports the use of CHS for routine pediatric eye care, demonstrating a favorable safety profile.
Purpose:
To determine safety and efficacy of oral chloral hydrate sedation (CHS) for outpatient pediatric ophthalmic procedures.
Design:
Prospective, interventional case series.
Methods:
Setting: King Khaled Eye Specialist Hospital.
Subjects:
Children aged 1 month to 5 years undergoing CHS for ocular imaging/evaluation.
Procedures:
Details on chloral hydrate dose administered, sedation achieved, vital signs, and adverse events were recorded.
Outcome Measures:
Primary outcome was percentage of patients with a sedation level ≥ 4 at 45 minutes post chloral hydrate administration. Secondary outcomes were time from sedation to discharge and adverse events, including changes in vital signs following chloral hydrate administration.
Results:
A total of 324 children were recruited with a mean age of 2.2 (SD: 1.3) years and mean weight of 10.9 (SD: 3.3) kg. Adequate sedation was obtained with a mean chloral hydrate first dose of 77.4 (SD: 14.7) mg/kg in 306 (94.4%) patients, with an additional 6 patients (1.9%) achieving adequate sedation with a second dose (overall adequate sedation: 96.3%). Mean reductions in heart rate, respiratory rate, and oxygen (O2) saturation from pre-sedation to 25 minutes post-sedation were 11.7 (SD: 14.3) beats per minute, 1.2 (SD: 2.4) breaths per minute, and 0.81% (SD: 1.2%), respectively (P < .001 for all). In multivariable regression, odds of remaining sedated 45 minutes after chloral hydrate administration were 2.53 times higher for American Society of Anesthesiologists (ASA) class II or III patients than for ASA class I (95% confidence interval [CI]: 1.11-5.78, P = .03), 1.03 times higher per mg increase in initial dose of chloral hydrate (95% CI: 1.01-1.06, P = .006), and 2.70 times higher per unit increase in number of planned procedures (95% CI: 1.63-4.47, P < .001). Three patients developed minor adverse events: 2 cases of O2 desaturation and 1 paradoxical reaction, none requiring significant intervention. Patients were discharged a median of 90 minutes after chloral hydrate administration.
Conclusion:
Chloral hydrate administered by a dedicated sedation service, as in this prospective assessment, can be used safely and effectively for outpatient pediatric ophthalmic procedures.
Related Concept Videos
Hydration of Cement
Aqueous Solutions and Heats of Hydration
When ionic compounds dissolve in water, the ions in the solid separate and disperse uniformly throughout the solution because water molecules surround and solvate the ions, reducing the strong electrostatic forces between them. This process...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:

